Multitrend Indo Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp232 (market cap 776.51B, 45.12M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume). The key difference: Multitrend Indo Tbk is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Multitrend Indo Tbk is more actively traded (45.12M versus 124.3K). Which is the better fit depends on your goals.
| BABY | DGNS | |
|---|---|---|
Market Cap | 776.51B | 319B |
Volume | 45.12M | 124.3K |
Lot | 451.21K | 1.24K |
Turnover | 11.77B | 28.28M |
Average Price | 260.94 | 227.48 |
Value | 11.77B | 28.28M |
Indicative Equilibrium Price | 232 | 228 |
Indicative Equilibrium Volume | 546 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →